Karin Anna Wallentin Wadt

Karin Anna Wallentin Wadt is a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. She specializes in Clinical Genetics with a focus on hereditary cancer syndromes and genetic counseling services within the Danish healthcare system (Region Hovedstaden).

Dr. Wadt's research centers on cancer genetics, particularly BRCA testing protocols, hereditary breast cancer management, pediatric cancer predisposition syndromes, and uveal melanoma genetics. Her work examines genetic risk assessment methodologies, clinical implementation of genetic testing, and the oncological outcomes associated with risk-reducing interventions. She has made significant contributions to understanding the practical applications of genetic discoveries in clinical oncology settings.

Analysis of Dr. Wadt's recent publications reveals a strong translational research focus bridging molecular genetics with clinical practice. Her work spans population-based studies of Danish BRCA carriers, international collaborations on pediatric cancer genomics, and comparative analyses of genetic counseling frameworks across European healthcare systems. The interdisciplinary nature of her research integrates clinical medicine, molecular diagnostics, epidemiology, and health policy perspectives to address real-world challenges in cancer genetics.

Dr. Wadt maintains active collaborations with researchers across Denmark and internationally, contributing to multi-center studies that have appeared in high-impact journals including Acta Oncologica, Leukemia, Breast Cancer Research and Treatment, and European Journal of Human Genetics. Her research has garnered attention through social media engagement, news coverage, and academic readership, reflecting its relevance to both scientific and clinical communities in the field of cancer genetics.